Airsculpt Technologies is trading 5.11% lower at $1.67, with no clear company-specific catalyst identified for the session.

  • No company-specific announcement or event was identified for October 1, 2026; the latest results release listed was August 10.
  • Earlier earnings weakness and investor investigations are background, not a confirmed trigger for the decline.
  • Healthcare shares are also lower, with XLV down 1.33%, while broader indices are mixed and do not establish a clear cause.